-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Erythromycin-ethylsuccinate-13C-d3
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/erythromycin-ethylsuccinate-13c-d3.gif)
| Category | Human immunodeficiency Virus (HIV) |
| Description | Erythromycin ethylsuccinate-13C,d3 is the 13C- and deuterium labeled Erythromycin Ethylsuccinate. Erythromycin Ethylsuccinate is an antibiotic useful for the treatment of a number of bacterial infections, has an antimicrobial spectrum similar to or slightly wider than that of penicillin. Erythromycin Ethylsuccinate has antiviral activity against HIV-1. |
Product Information
| Synonyms | HY-B0957S|Erythromycin ethylsuccinate-13C,d3 |
| Molecular Weight | 866.06 |
| Molecular Formula | C43H75NO16 |
| Boiling Point | 874.1ºC at 760 mmHg |
| Flash Point | 482.4ºC |
| Purity | ≥98% |
| Density | 1.21g/cm3 |
| Solubility | DMF: 15 mg/ml, DMSO: 15 mg/ml, Ethanol: 30 mg/ml |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Index Of Refraction | 1.528 |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| PSA | 226.28000 |
| Target | Bacterial; HIV; Autophagy; Antibiotic |
